Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
75,267
Employees75,267
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
75,267
Employees75,267

NVS Key Statistics

Market cap
309.77B
Market cap309.77B
Price-Earnings ratio
21.72
Price-Earnings ratio21.72
Dividend yield
2.01%
Dividend yield2.01%
Average volume
2.16M
Average volume2.16M
High today
$154.96
High today$154.96
Low today
$152.31
Low today$152.31
Open price
$154.20
Open price$154.20
Volume
7.22M
Volume7.22M
52 Week high
$170.46
52 Week high$170.46
52 Week low
$112.34
52 Week low$112.34

NVS News

Benzinga 11h
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal

The agreement could generate up to $1.9 billion for Antares, including upfront and milestone payments. Antares To Receive $105 Million Upfront The agreement a...

Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal
Seeking Alpha 13h
Novartis and Antares to develop cancer drugs in a deal worth up to $1.9B

Privately held Antares Therapeutics on Wednesday announced a collaboration with Novartis (NVS) (NVSEF) to develop and market cancer drugs as part of a deal wort...

Novartis and Antares to develop cancer drugs in a deal worth up to $1.9B

Analyst ratings

46%

of 28 ratings
Buy
35.7%
Hold
46.4%
Sell
17.9%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.